esmolol has been researched along with Auricular Flutter in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, F; Imamura, M; Masamune, T; Nonaka, A; Suzuki, S | 1 |
| Appunn, DO; Shettigar, UR; Toole, JG | 1 |
| Hilleman, DE; Mohiuddin, SM; Mooss, AN; Reyes, AP; Scott, W; Seyedroudbari, A; Sugimoto, JT; Wurdeman, RL | 1 |
| Das, G; Michelson, EL; Platia, EV; Porterfield, JK | 1 |
| Bateman, TM; Conklin, CM; Czer, LS; Gray, RJ; Matloff, JM | 1 |
| Burge, J; Katz, RJ; Keefe, D; Laddu, AR; Somberg, JC; Steinberg, JS | 1 |
| MacVaugh, H; Michelson, EL; Sawin, HS; Schwartz, M | 1 |
5 trial(s) available for esmolol and Auricular Flutter
| Article | Year |
|---|---|
Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Atrial Flutter; Digoxin; Drug Therapy, Combination; Heart Rate; Humans; Propanolamines; Time Factors | 1993 |
Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Cost-Benefit Analysis; Diltiazem; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Probability; Prognosis; Propanolamines; Reference Values; Survival Rate; Treatment Outcome | 2000 |
Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Digoxin; Female; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic; Propanolamines; Random Allocation; Verapamil | 1989 |
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Female; Fluorobenzenes; Half-Life; Humans; Hypotension; Male; Middle Aged; Myocardial Contraction; Propanolamines; Time Factors | 1986 |
Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Coronary Artery Bypass; Female; Heart Rate; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Propanolamines; Time Factors | 1988 |
2 other study(ies) available for esmolol and Auricular Flutter
| Article | Year |
|---|---|
[Successful control of rapid heart rate with atrial flutter by intravenous administration of esmolol in a patient after total correction of the tetralogy of Fallot].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Atrial Flutter; Dilatation and Curettage; Female; Humans; Postoperative Care; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Tachycardia, Supraventricular; Tetralogy of Fallot; Treatment Outcome | 2004 |
Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Cardiac Surgical Procedures; Digoxin; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypotension; Infusions, Parenteral; Middle Aged; Postoperative Complications; Premedication; Propanolamines; Tachycardia | 1985 |